| Company Name: | Alliance HealthCare Services Inc | | Ticker Symbol: | AIQ | | | WWW Address: | www.allianceimaging.com |
| CEO: | Larry C. Buckelew | | No. of Employees: | 1,720 |
| Common Issue Type: | CS | | Business Description: | Alliance HealthCare Services Inc., together with its subsidiaries, provides outpatient diagnostic imaging and radiation therapy services in the United States.
|
| | | Industry Information: | HEALTH SERVICES - Medical Laboratories & Research [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 6.89 |  0.0 | - | - | | 13.09 | 12.63 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 73.2 | 10.6 | 0.95 | -1.12 | 0.00 | 0.0 | 0.0 | 13.40 - 3.61 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 12.80 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 73.2 | mil |
| Latest Shares Outstanding | 10.6 | mil |
| Earnings pS (EPS) | -1.12 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 274,569 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 5.0 | mil |
| Float as % of Shares Outstanding | 46.9 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 16.80 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 47.7 | % |
| EBITDA Margin | 30.9 | % |
| Pre-Tax Profit Margin | -0.5 | % |
| Assets Turnover | 0.8 | % |
| Return on Assets (ROA) | -0.1 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -0.2 | % |
| Current Ratio | 1.6 | |
| Leverage Ratio (Assets/Equity) | 0.0 | |
| Interest Cover | 0.9 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 146.0 | % |
| Working Capital pS | 4.23 | $ |
| Cash pS | 2.89 | $ |
| Book-Value pS | 0.00 | $ |
| Tangible Book-Value pS | -32.59 | $ |
| Cash Flow pS | 9.00 | $ |
| Free Cash Flow pS | 3.39 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.00 | |
| Price/Tangible Book Ratio | -0.39 | |
| Price/Cash Flow | 1.4 | |
| Price/Free Cash Flow | 3.8 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.7 | 103 | 229 | 1,278 |
| 4 Weeks | 13.40 | 10.52 | 11.48 | 11.5 | 107 | 345 | 6,551 |
| 13 Weeks | 13.40 | 6.68 | 6.97 | 83.6 | 169 | 219 | 13,815 |
| 26 Weeks | 13.40 | 5.85 | 6.00 | 113.3 | 182 | 192 | 23,802 |
| 52 Weeks | 13.40 | 3.61 | 5.25 | 143.8 | 195 | 229 | 56,904 |
| YTD | 13.40 | 6.25 | - | 100.6 | 173 | 204 | 20,217 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 12.67 | 12.61 | 10.24 | 7.87 | 7.52 | 0.95 | 1.93 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -0.09 | 0.2 | -1.15 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -20.40 | NA | -17.96 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -8.6 | -8.6 | -4.3 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.22 | 0.22 | 13.93 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 8.05 |
| Current Ratio | 1.5 |
| Quick Ratio (Acid Test) | 1.3 |
| Liquidity Ratio (Cash) | 0.48 |
| Receivables Turnover | 6.7 |
| Average Collection Period | 54 |
| Working Capital/Equity | -27.4 |
| Working Capital pS | 4.25 |
| Cash-Flow pS | 9.39 |
| Free Cash-Flow pS | 5.14 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.31 |
| Financial Leverage Ratio (Assets/Equity) | 0.0 |
| Debt Ratio | 129.4 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 168.5 |
| LT Debt/Total Liabilities | 75.2 |
| Interest Cover | 0.9 |
| Interest/Capital Invested | 11.35 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 8.55 |
| Tobin's Q Ratio | 0.24 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 5.64 |
| Enterprise Value (EV)/Free Cash Flow | 10.42 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -0.39 |
| Price/Book Ratio - LTM | 0.00 |
| Price/Cash Flow Ratio | 1.4 |
| Price/Free Cash Flow Ratio - LTM | 3.8 |
| Price/Sales Ratio | 0.29 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 12.5 |
| PER SHARE FIGURES |
| LT Debt pS | 51.39 |
| Current Liabilities pS | 7.87 |
| Tangible Book Value pS - LTM | -32.59 |
| Book Value pS - LTM | 0.00 |
| Capital Invested pS | 35.82 |
| Cash pS - LTM | 2.89 |
| Cash Flow pS - LTM | 9.00 |
| Free Cash Flow pS - LTM | 3.39 |
| Earnings pS (EPS) | -1.12 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 11.55 |
| Free Cash Flow Margin 5YEAR AVG | 4.31 |
| Net Profit Margin | -0.2 |
| Net Profit Margin - 5YEAR AVRG. | 0.6 |
| Equity Productivity | -2.87 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.24 |
| Return on Capital Invested (ROCI) | -0.3 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 0.5 |
| Assets Productivity | 0.80 |
| Return on Assets (ROA) | -0.2 |
| Return on Assets (ROA) - 5YEAR AVRG. | 0.4 |
| Gross Profit Margin | 47.7 |
| Gross Profit Margin - 5YEAR AVRG. | 46.2 |
| EBITDA Margin - LTM | 30.9 |
| EBIT Margin - LTM | 10.9 |
| Pre-Tax Profit Margin | -1.7 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -8.8 |
| Effective Tax Rate | 85.2 |
| Effective Tax Rate - 5YEAR AVRG. | 38.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 50 |
| Revenue per Employee | 274,569 |
| Net Income per Employee | -676 |
| Average Collection Period | 50 |
| Receivables Turnover | 6.7 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 3.39 |
| Assets/Revenue | 1.25 |
| Net Working Capital Turnover | 10.47 |
| Fixed Assets Turnover | 1.09 |
| Total Assets Turnover | 0.8 |
| Revenue per $ Cash | 11.81 |
| Revenue per $ Plant | 2.26 |
| Revenue per $ Common Equity | -2.87 |
| Revenue per $ Capital Invested | 1.24 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 16.8 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 14.7 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
